
Large-scale study shows risk of breast and ovarian cancer differs by type of BRCA1, BRCA2 mutation.
In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at The Basser Center for BRCA, the Abramson Cancer Center, and the University of Pennsylvania identified mutations that are associated with significantly different risks of breast and ovarian cancers. The researchers state the results, which show that some mutations confer higher risks of breast cancer, while other … Continue reading Large-scale study shows risk of breast and ovarian cancer differs by type of BRCA1, BRCA2 mutation.